5Panagopoulou P, Filioti J, Petrikkos G, et al. Environmental surveillance of filamentous fungi in three tertiary care hospitals in Greece. J Hosp Infect,2002,52(3): 185-191.
6Bow EJ. Invasive fungal infections in patients receiving intensive cytotoxic therapy for cancer [J]. Br J Haematol,1998,101(Suppl 1):1- 4.
7Panagopoulou P,Filioti J,Petrikkos G,et al. Environmental surveillance of filamentous fungi in three tertiary care hospitals in Greece [J]. J Hosp Infect,2002,52(3):185- 191.
8St-Germain G, Laverdiere M, Pelletier R, et al. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada [J]. J Clin Microbiol,2001,39(3):949- 953.
9Mullen CA,Abd El-Baki H,Samir H,et al. Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients [J]. Support Care Cancer, 2003,11(5):321- 325.
10Nucci M, Silveira MI, Spector N, et al. Risk factors for death among cancer patients with fungemia [J]. Clinical Infectious Diseases, 1998,27(1):107- 111.
